Edition:
United States

WebMD Health Corp (WBMD.OQ)

WBMD.OQ on NASDAQ Stock Exchange Global Select Market

53.02USD
9 Dec 2016
Change (% chg)

-- (+0.00%)
Prev Close
$53.02
Open
$53.10
Day's High
$53.38
Day's Low
$52.83
Volume
184,533
Avg. Vol
205,542
52-wk High
$67.55
52-wk Low
$45.48

Summary

Name Age Since Current Position

Martin Wygod

76 2005 Chairman of the Board

Steven Zatz

59 2016 President, Chief Executive Officer, Director

Blake DeSimone

40 2016 Chief Financial Officer, Executive Vice President

Douglas Wamsley

57 2012 Executive Vice President, Co-General Counsel, Secretary

Michael Glick

59 2012 Executive Vice President, Co-General Counsel

Mark Adler

59 2005 Independent Director

Neil Dimick

67 2005 Independent Director

Jerome Keller

74 2005 Independent Director

James Manning

69 2005 Independent Director

William Marino

72 2014 Independent Director

Joseph Smith

77 2009 Independent Director

Stanley Trotman

73 2005 Independent Director

Kristiina Vuori

48 2014 Independent Director

Risa Fisher

Investor Relations Officer

Biographies

Name Description

Martin Wygod

Mr. Martin J. Wygod serves as Chairman of the Board of WebMD Health Corp. From March 2001 until the Merger in October 2009, Mr. Wygod served as HLTH’s Chairman of the Board and served as a member of its Board of Directors from September 2000 until the Merger. Mr. Wygod also served as HLTH’s Acting Chief Executive Officer from February 2008 until the Merger and as its Chief Executive Officer from September 2000 until May 2003. He is also engaged in the business of racing and breeding thoroughbred horses. Mr. Wygod’s qualifications for membership on WebMD’s Board of Directors include: his prior service as an executive officer and director of WebMD, HLTH and predecessor companies and as an executive officer and director of other companies in the healthcare industry.

Steven Zatz

Dr. Steven L. Zatz, M.D., serves as President, Chief Executive Officer, Director of Webmd Health Corp. He served as President of WebMD, overseeing WebMD’s consumer and professional websites and services. Prior to that, Dr. Zatz had served as Executive Vice President, Professional Services of WebMD from July 2005 to August 2013, providing leadership for WebMD’s professional websites and services including its flagship site for healthcare professionals, Medscape.com. From October 2000 to July 2005, Dr. Zatz had similar responsibilities at HLTH, where he focused on the physician portals. Dr. Zatz was Senior Vice President, Medical Director of CareInsite, Inc. from June 1999 until its acquisition by HLTH in September 2000. Prior to joining CareInsite, Dr. Zatz was a Senior Vice President of RR Donnelly Financial in charge of its healthcare business from October 1998 to May 1999. From August 1995 to May 1998, Dr. Zatz was President of Physicians’ Online, an online portal for physicians.

Blake DeSimone

Mr. Blake DeSimone serves as Chief Financial Officer, Executive Vice President of the Company. Mr. DeSimone, had served as Senior Vice President – Finance of WebMD since joining WebMD in June 2015. In that role, he was responsible for the Company’s SEC and financial reporting, financial planning and analysis, and treasury management. Prior to joining WebMD, Mr. DeSimone served as Chief Financial Officer of D+M Holdings, a global consumer electronics company, from 2010 to June 2015. From 2007 to 2010, he was President and Chief Financial Officer of Advogent Group, Inc., a services company providing sales and marketing support to the healthcare industry. Prior to that, he served in executive roles at Cardinal Health and Boron Lepore & Associates, Inc. Mr. DeSimone is a Certified Public Accountant and started his career in Arthur Andersen’s Assurance Practice.

Douglas Wamsley

Mr. Douglas W. Wamsley serves as Executive Vice President, Co-General Counsel and Secretary of WebMD Health Corp. Mr. Wamsley served as Executive Vice President, General Counsel and Secretary of WebMD from July 2005 until May 2012, when he began to serve as Executive Vice President, Co-General Counsel and Secretary. From September 2001 until July 2005, Mr. Wamsley served as Senior Vice President — Legal of HLTH, focusing on its WebMD segment.

Michael Glick

Mr. Michael B. Glick is Executive Vice President, Co-General Counsel of WebMD Health Corp. He became Executive Vice President and Co-General Counsel of WebMD in May 2012. He served as Senior Vice President and Assistant General Counsel of WebMD from 2007 until May 2012 and, before that, had served as Senior Vice President and Assistant General Counsel of HLTH and its predecessors for more than five years.

Mark Adler

Dr. Mark J. Adler, M.D., serves as an Independent Director of WebMD Health Corp. From September 2000 until completion of WebMD’s merger with HLTH Corporation (which we refer to as HLTH), the former parent company of WebMD, in October 2009 (which we refer to as the Merger), Dr. Adler was a member of HLTH’s Board of Directors. Since 2014, Dr. Adler has also served as Strategic Advisor to, and as a member of the Scientific Advisory Board of, Biological Dynamics, Inc., a privately held biotechnology company, and is currently the Chairman of that Scientific Advisor Board. He is also currently a director of the San Diego Cancer Research Institute. Dr. Adler is an oncologist and served for over 10 years as Chief Executive Officer of the San Diego Cancer Center until its acquisition in February 2011 by the University of California, San Diego UCSD). Following that acquisition, he continued with UCSD Oncology as Director of Strategic Development from February 2011 until February 2014. Until April 2006, Dr. Adler had served, for more than five years, as the Chief Executive Officer of the combined internal medicine and oncology group of Medical Group of North County in San Diego, California. Dr. Adler’s qualifications for membership on WebMD’s Board of Directors include: his many years of experience as a physician and an executive of a physician practice; his involvement with early stage biotechnology companies; and his prior service as a director of WebMD, HLTH and predecessor companies.

Neil Dimick

Mr. Neil F. Dimick, CPA, serves as Independent Director of WebMD Health Corp. From December 2002 until completion of the Merger in October 2009, Mr. Dimick was a member of HLTH’s Board of Directors. Mr. Dimick served as Executive Vice President and Chief Financial Officer of AmerisourceBergen Corporation, a wholesale distributor of pharmaceuticals, from 2001 to 2002, and as Senior Executive Vice President and Chief Financial Officer and as a director of Bergen Brunswig Corporation, a wholesale distributor of pharmaceuticals, for more than five years prior to its merger in 2001 with AmeriSource Health Corporation to form AmerisourceBergen. He also serves as a member of the boards of directors of the following companies: Alliance Imaging Inc., a provider of outsourced diagnostic imaging services to hospitals and other healthcare companies; Global Resources Professionals, an international professional services firm that provides outsourced services to companies on a project basis; and Mylan Laboratories, Inc., a pharmaceutical manufacturer. Mr. Dimick previously served as a member of the board of directors of Thoratec Corporation, a developer of products to treat cardiovascular disease, for more than five years prior to its acquisition by St. Jude Medical, Inc. in October 2015.

Jerome Keller

Mr. Jerome C. Keller serves as Independent Director of WebMD Health Corp. From 1997 until he retired in October 2005, Mr. Keller served as Senior Vice President, Sales and Marketing at Martek Biosciences Corporation, a company that develops and sells microalgae products, and he served as a member of its Board of Directors from October 2005 until its acquisition by Royal DSM N.V. in February 2011. He served as Vice President of Sales for Merck & Co. Inc., a pharmaceutical company, from 1986 to 1993.

James Manning

Mr. James V. Manning serves as Independent Director of WebMD Health Corp. From September 2000 until completion of the Merger in October 2009, Mr. Manning was a member of HLTH’s Board of Directors. Prior to that, he was a member of a predecessor company’s board of directors for more than five years. Mr. Manning’s qualifications for membership on WebMD’s Board of Directors include: his prior service as a director of WebMD, HLTH and predecessor companies in the healthcare industry; his experience as a chief financial officer of several public companies (including of Medco Containment Services, Inc. for more than five years prior to 1994); and his experience, prior to that, as a CPA and partner of a major public accounting firm.

William Marino

Mr. William J. (Bill) Marino serves as Independent Director of WebMD Health Corp. Mr. Marino served as Chairman, President and Chief Executive Officer of Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ), the state’s largest health insurer, until he retired in 2011. During that time, he also served as Co-Chairman of America’s Health Insurance Plans (AHIP), Chairman of the National Institute for Health Care Management (NIHCM) and on the Board of Directors of the Blue Cross Blue Shield Association (BCBSA). Before joining Horizon BCBSNJ, Mr. Marino was Vice President of Regional Group Operations for New York and Connecticut for the Prudential, capping a 23-year career with them. Mr. Marino is also a member of the Board of Directors of two other publicly-traded corporations: Sealed Air Corporation (for which he has been a Board member since 2002 and has served as the non-executive Chairman of the Board since May 2014) and Sun Bancorp, Inc. (for which he has been a Board member since 2010). He serves on the Board of Directors of Secura Home Health LLC, a privately held company. He has also served as the Chairman and Co-Chairman of the Board of Directors of the New Jersey Performing Arts Center (NJPAC) and is currently the Chairman of the Board of Theater Square Development Corporation, LLC, NJPAC’s real estate development subsidiary. He is also a member of: the Board of the New Jersey Symphony Orchestra; the Campaign Committee of Saint Vincent Academy; and the Board of Trustees of Delbarton School in Morristown.

Joseph Smith

Mr. Joseph E. (Joe) Smith serves as Independent Director of WebMD Health Corp. He became a member of WebMD’s Board of Directors in October 2009, upon completion of the Merger. Mr. Smith was a member of HLTH’s Board of Directors from September 2000 until the Merger. Mr. Smith served in various positions with Warner-Lambert Company, a pharmaceutical company, from March 1989 to September 1997, the last of which was Corporate Executive Vice President and a member of the Office of the Chairman and the firm’s Management Committee. Mr. Smith was a member of the Board of Directors of Par Pharmaceutical Companies, Inc., a manufacturer and distributor of generic and branded pharmaceuticals, for more than five years prior to its acquisition by affiliates of TPG in September 2012. Mr. Smith is a member of the Board of Directors of NovaMedica, a privately held pharmaceutical company.

Stanley Trotman

Mr. Stanley S. Trotman, Jr., is no longer a Independent Director of WebMD Health Corp., effective September 29, 2016. Mr. Trotman retired in 2001 from UBS Financial Services, Inc. after it acquired, in 2000, PaineWebber Incorporated, an investment banking firm where he had been a Managing Director with the Health Care Group since 1995. He serves as a member of the board of directors of American Shared Hospital Services, a public company that provides radiosurgery services to medical centers for use in brain surgery.

Kristiina Vuori

Dr. Kristiina S. Vuori M.D., Ph.D. serves as Independent Director of Webmd Health Corp. Dr. Vuori has been President of Sanford-Burnham Medical Research Institute since 2010 and its Interim CEO since 2013, leading the Institute’s academic, scientific and general operations. The Institute is a non-profit research organization dedicated to discovering the fundamental molecular causes of disease and devising the innovative therapies of tomorrow, with major research programs in cancer, neurodegeneration, diabetes, and infectious, inflammatory, and childhood diseases. Dr. Vuori also holds the Pauline and Stanley Foster Presidential Chair at the Institute and serves as Professor at the Institute’s National Cancer Institute (NCI)-designated Cancer Center, an interdisciplinary basic and translational research effort mobilizing over 400 scientists. From 2005 until 2013, Dr. Vuori also led the Cancer Center. Dr. Vuori earned her M.D. and Ph.D. degrees at University of Oulu, Finland. After completing her internship and residency, she received postdoctoral training at Sanford-Burnham from 1992 to 1995 and was appointed to the faculty in 1996. Dr. Vuori has received numerous research grants and awards from NIH, NCI, Department of Defense (DoD), Stand Up To Cancer Dream Team, and the California Cancer Research Programs. She also serves in a wide variety of advisory capacities to NCI and other cancer organizations, including advisory roles for the NCI’s Developmental Therapeutics Program, Center for Strategic Scientific Initiatives, and the National Cancer Advisory Board. Additionally, Dr. Vuori serves on the Boards of Directors for the American Association for Cancer Research (AACR), the California Institute for Regenerative Medicine (CIRM), and the California Breast Cancer Research Council. She has also served on numerous editorial boards for scientific journals and institutional scientific advisory boards.

Risa Fisher

Basic Compensation

Name Fiscal Year Total

Martin Wygod

3,673,430

Steven Zatz

4,270,100

Blake DeSimone

--

Douglas Wamsley

2,003,520

Michael Glick

2,016,890

Mark Adler

273,627

Neil Dimick

290,127

Jerome Keller

267,127

James Manning

289,127

William Marino

277,127

Joseph Smith

269,627

Stanley Trotman

269,627

Kristiina Vuori

267,127

Risa Fisher

--
As Of  30 Dec 2015